Suppr超能文献

新药的大规模受体筛选。

Mass receptor screening for new drugs.

作者信息

Burch R M, Kyle D J

机构信息

Nova Pharmaceutical Corporation, Baltimore, Maryland 21224.

出版信息

Pharm Res. 1991 Feb;8(2):141-7. doi: 10.1023/a:1015819431855.

Abstract

Mass receptor screening is capable of identifying drug candidates in large compound libraries. Our laboratory has developed a mass screening technology by standardizing assay protocols that can be transferred from receptor to receptor. The entire operation, from disbursement of compounds to data analysis, is computerized to handle vast numbers of experimental results. The success of this method depends upon strict definitions of compound activity, with rapid elimination of compounds that do not fulfill all criteria. Finally, we approach automation with caution. While certain items, such as automatic harvesters, are essential for high-throughput screening, much time can be spent optimizing gadgets instead of gathering data.

摘要

质谱受体筛选能够在大型化合物库中识别候选药物。我们实验室通过标准化检测方案开发了一种质谱筛选技术,该方案可在不同受体之间转移。从化合物分发到数据分析的整个操作过程均实现了计算机化,以处理大量实验结果。该方法的成功取决于对化合物活性的严格定义,要迅速淘汰不符合所有标准的化合物。最后,我们谨慎对待自动化。虽然某些设备,如自动收获仪,对于高通量筛选至关重要,但可能会花费大量时间优化这些设备而不是收集数据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验